Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches

Published:2020-10 Issue: Volume:885 Page:173503
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Ram Chetan,Jha Ankush Kumar,Ghosh Aparajita,Gairola Shobhit,Syed Abu Mohammad,Murty Upadhyayula Suryanarayana,Naidu V.G.M.,Sahu Bidya Dhar

Funder

Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India

National Institute of Pharmaceutical Education and Research

Publisher

Elsevier BV

Subject

Pharmacology

Reference162 articles.

1. Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management;Adhami;Biochem. Pharmacol.,2012

2. NOD-like and Toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner;Anders;Kidney Int.,2013

3. The inflammasomes in kidney disease;Anders;J. Am. Soc. Nephrol.,2011

4. Beyond tissue injury - damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis;Anders;J. Am. Soc. Nephrol.,2014

5. Anti-inflammatory effects of luteolin: a review of in vitro, in vivo, and in silico studies;Aziz;J. Ethnopharmacol.,2018

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inibidores de SGLT2 e inflamassoma NLRP3: alvo potencial na doença renal do diabetes;Brazilian Journal of Nephrology;2024-12

2. SGLT2 inhibitors and NLRP3 inflammasome: potential target in diabetic kidney disease;Brazilian Journal of Nephrology;2024-12

3. Exploring the glycation association with dyslipidaemia: Novel approach for diabetic nephropathy;Biochemical Pharmacology;2024-11

4. Tonabersat suppresses priming/activation of the NOD-like receptor protein-3 (NLRP3) inflammasome and decreases renal tubular epithelial-to-macrophage crosstalk in a model of diabetic kidney disease;Cell Communication and Signaling;2024-07-05

5. Research progress on Alpinia oxyphylla in the treatment of diabetic nephropathy;Frontiers in Pharmacology;2024-06-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3